Question-and-Answer Session
Operator
(Operator Instruction). And we will hear first from Michael Weinstein with J.P. Morgan.
Chris Rogers
Hi guys this is Chris Rogers calling here for Mike. Couple of questions Mike, couple of questions. First, Scott, can you expand on the type of deal you are looking, over size or potential transaction or the therapeutic area?
Scott Huennekens
Exactly what we have talked about in the past products that would be in a coronary and peripheral therapy space with balloons and stents and stands and the like?
John Dahldorf
Given the confidentiality agreements around I can’t really give you any more details than that.
Chris Rogers
Okay. And then on the guidance, can you talk a little bit on what you saw in the past couple of months the drove the increase in the top line expectations?
Scott Huennekens
Yeah, across the board we are on schedule with our programs sort of REVO program with the s5i where we’ve seen our backlog for consoles and opportunities for consoles around the world, gaining all the regulatory approvals and timings for lunching the catheters and the orders that we have, all those things are just going very, very well.
Chris Rogers
Okay. And then just one last question?
Scott Huennekens
Looking for the average, John?
John Dahldorf
Yeah, I think that the disposable growth both on the IVUS side and the trends that we see on the FM side leads us to be very confident with the – that we will continue to see that throughout the year.
Chris Rogers
Okay great. One last quick one, Japanese disposable sales are going to be strong this quarter, are there any impact or onetime kind of bulk stocking orders from distributors that we saw last quarter or you can say what you saw this quarter organic demand?
Scott Huennekens
We believe that the stocking orders really kind of happened in the fourth quarter and what we are seeing now the kind of true run rates of the business.
Chris Rogers
Okay great thank you
John Dahldorf
And you will see a increase Chris and run rate next quarter when we fully market released s5i with revolution and on it Japan. So that will be available on a broader platform, it was available on IVG, now its getting available on the s5 family in Q3. So that’s a bigger base that the product will be available on. And that’s another part of our – the expectations for revenue growth.
- To read the full transcript on Seeking Alpha, click here »
